Feedback / Questions
elritercept (KER-050) - Takeda
Elritercept: Regulatory filing for 2L Anemia-associated MDS in FY2027-FY2029
(Takeda)
-
Jul 30, 2025 -
Q1 FY2025 Results
Filing
•
Hematological Malignancies • Myelodysplastic Syndrome • Oncology
https://assets-dam.takeda.com/image/upload/v1753839858/Global/Investor/Financial-Results/FY2025/Q1/qr2025_q1_p01_en.pdf
Jul 30, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious